Information Journal Paper
APA:
Copy. (2020). SARS-CoV-2cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor. CELL, 181(-), 0-0. SID. https://sid.ir/paper/1044388/en
Vancouver:
Copy. SARS-CoV-2cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor. CELL[Internet]. 2020;181(-):0-0. Available from: https://sid.ir/paper/1044388/en
IEEE:
Copy, “SARS-CoV-2cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor,” CELL, vol. 181, no. -, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/1044388/en